IP Library Granted Patent US 8,781,576
Granted Patent B2
US 8,781,576 · App. 13/312,910 · Granted Jul 15, 2014

Device and method for reducing patient transthoracic impedance for the purpose of delivering a therapeutic current

Inventors: Walter T. Savage (Concord, CA); Shelley J. Savage (Concord, CA); Walter N. Maclay (Sunnyvale, CA); Douglas C. Morrison (Union City, CA); Thomas K. Geraty (San Jose, CA); Mark D. Brinkerhoff (San Jose, CA); Ronald S. Boeder (Livermore, CA); Tony M. Ton (San Diego, CA); Jeffrey S. Greger (Fairfield, CA); Peter Gray (Vallejo, CA)
Assignee: Cardiothrive, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,781,576
App. No.
13/312,910
Granted
Jul 15, 2014
Kind
B2
Abstract

A device and method for reducing patient transthoracic impedance for the purpose of delivering a therapeutic current are provided. In one embodiment, the device for reducing patient transthoracic impedance for the purpose of delivering a therapeutic current may be used in a defibrillator. The device for reducing patient transthoracic impedance for the purpose of delivering a therapeutic current may be a microneedle array that may have a number of different configurations and may be made with different materials.

Claims (23)

1. A defibrillator, comprising:

two paddles for delivering a shock to a patient;

each paddle having a microneedle array with two or more rows of conductive microneedles;

a device for generating a therapeutic current to deliver the shock to the patient through the two paddles, wherein the device has at least a battery and a capacitor and is partially incorporated within the paddles; and

wherein the microneedle array of the two paddles applies a voltage and causes electroporation of a skin surface of the patient and delivers the shock to the patient through the skin surface.

2. The defibrillator of claim 1 , wherein each microneedle in the microneedle array has the same shape.

3. The defibrillator of claim 1 , wherein each microneedle in the microneedle array has a different shape.

4. The defibrillator of claim 1 , wherein each microneedle in the microneedle array has a cylindrical shape.

5. The defibrillator of claim 1 , wherein each microneedle in the microneedle array has a pyramidal shape.

6. The defibrillator of claim 5 , wherein each pyramidal shaped microneedle further comprises one more portions that extend from a surface of the pyramidal shaped microneedle to increase an effective surface area of the pyramidal shaped microneedle.

7. The defibrillator of claim 1 , wherein each microneedle in the microneedle array has one of a prism shape, a curved blade shape and a C-channel shape.

8. The defibrillator of claim 1 , wherein each paddle has the microneedle array around an outer circumference of the paddle.

9. The defibrillator of claim 1 , wherein the microneedle array is a first quadrant of microneedles, a second quadrant of microneedles, a third quadrant of microneedles and a fourth quadrant of microneedles wherein the four quadrants are separated from each other.

10. The defibrillator of claim 1 , wherein the microneedle array is at least a first quadrant of microneedles and a second quadrant of microneedles wherein the quadrants are separated from each other.

11. The defibrillator of claim 1 , wherein each microneedle is constructed from one of a pharmaceutical grade stainless steel, gold, titanium, nickel, iron, gold, platinum, tin, chromium, copper, alloys, silicon, silicon dioxide, capacitive carbon, graphite and polymers.

12. The defibrillator of claim 1 , wherein each microneedle is constructed from a biocompatible material.

13. The defibrillator of claim 1 further comprising an impedance sensor that measures a depth of skin surface penetration of the microneedles.

14. A method for reducing patient transthoracic impedance for the purpose of delivering a therapeutic current, the method comprising:

providing a microneedle array having two or more rows of microneedles;

performing electroporation of a skin surface of the patient by applying a voltage using the microneedle array;

puncturing one or more layers of the skin surface using the microneedle array; and

delivering a therapeutic current and a shock through the skin surface of the patient using the microneedle array at a reduced power due to a reduced transthoracic impedance caused by the electroporation and/or the microneedles.

15. The method of claim 14 further comprising determining, using an impedance sensor, a depth of penetration in the skin surface of the microneedles.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 20, 2012
From: SAVAGE, WALTER T.; SAVAGE, SHELLEY J.; MACLAY, WALTER N.; MORRISON, DOUGLAS C.; GERATY, THOMAS K.; BRINKERHOFF, MARK D.; BOEDER, RONALD S.; TON, TONY M.; GREGER, JEFFREY S.; GRAY, PETER
To: CARDIOTHRIVE, INC.
Reel/Frame 028082/0108 →
Continuity (3)
Continuation In Part 12724269 · Mar 15, 2010
Provisional Application 61161014 · Mar 17, 2009
Related Publication 20120310315A1 · Dec 6, 2012